The Philippine Health Insurance Corporation (PhilHealth) has announced an enhancement to its Z Benefit Package for Peritoneal ...

The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.

The Philippine Health Insurance Corporation (PhilHealth) has substantially enhanced its Z Benefit Package for Peritoneal Dialysis, this time with separate packages for adult and pediatric patients, ...

A randomized trial and nonrandomized clinical experience have demonstrated lower rates of infection and longer ... subcutaneous alternative to hemodialysis catheters. It combines port and catheter ...

Clinicians experienced with the use of subcutaneous dialysis catheter systems indicate that device-related infections often can be treated with systemic antibiotics and antimicrobial solution ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond ...

Dr. Greg Vigna, MD, JD, national malpractice attorney and PICC line sepsis attorney, says, “Central-line associated bloodstream infections ... PICC lines, dialysis catheters, and other central ...

The researchers found that within the first month postinsertion, there were no significant intergroup differences in terms of infection ... for peritoneal dialysis catheter implantation," the ...

Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...